Vanguard Group
REPL icon

Vanguard Group’s Replimune Group REPL Stock Holding History

Vanguard Group’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$36.7M Buy
3,776,198
+296,803
+9% +$2.52M ﹤0.01% 2335
2025
Q3 		$14.6M Buy
3,479,395
+9,707
+0.3% +$62K ﹤0.01% 2779
2025
Q2 		$32.2M Sell
3,469,688
-363,345
-9% -$3.17M ﹤0.01% 2329
2025
Q1 		$37.4M Buy
3,833,033
+237,185
+7% +$2.94M ﹤0.01% 2222
2024
Q4 		$43.5M Buy
3,595,848
+129,601
+4% +$1.57M ﹤0.01% 2225
2024
Q3 		$38M Buy
3,466,247
+571,133
+20% +$5.8M ﹤0.01% 2296
2024
Q2 		$26.1M Buy
2,895,114
+124,786
+5% +$870K ﹤0.01% 2443
2024
Q1 		$22.6M Buy
2,770,328
+32,555
+1% +$267K ﹤0.01% 2540
2023
Q4 		$23.1M Buy
2,737,773
+141,654
+5% +$1.64M ﹤0.01% 2530
2023
Q3 		$44.4M Buy
2,596,119
+242,220
+10% +$4.76M ﹤0.01% 2187
2023
Q2 		$54.7M Sell
2,353,899
-28,492
-1% -$557K ﹤0.01% 2143
2023
Q1 		$42.1M Buy
2,382,391
+139,399
+6% +$3.31M ﹤0.01% 2251
2022
Q4 		$61M Buy
2,242,992
+394,825
+21% +$8.2M ﹤0.01% 2077
2022
Q3 		$31.9M Buy
1,848,167
+89,618
+5% +$1.71M ﹤0.01% 2405
2022
Q2 		$30.7M Buy
1,758,549
+132,791
+8% +$2.18M ﹤0.01% 2426
2022
Q1 		$27.6M Buy
1,625,758
+81,845
+5% +$1.54M ﹤0.01% 2604
2021
Q4 		$41.8M Sell
1,543,913
-16,856
-1% -$504K ﹤0.01% 2459
2021
Q3 		$46.3M Buy
1,560,769
+135,051
+9% +$4.39M ﹤0.01% 2409
2021
Q2 		$54.8M Sell
1,425,718
-113,380
-7% -$3.88M ﹤0.01% 2320
2021
Q1 		$47M Buy
1,539,098
+135,151
+10% +$5.06M ﹤0.01% 2351
2020
Q4 		$53.6M Buy
1,403,947
+303,198
+28% +$12.6M ﹤0.01% 2164
2020
Q3 		$25.3M Buy
1,100,749
+215,158
+24% +$4.9M ﹤0.01% 2334
2020
Q2 		$22M Buy
885,591
+113,323
+15% +$2M ﹤0.01% 2374
2020
Q1 		$7.7M Sell
772,268
-27,627
-3% -$412K ﹤0.01% 2738
2019
Q4 		$11.5M Buy
799,895
+256,947
+47% +$3.7M ﹤0.01% 2796
2019
Q3 		$7.55M Buy
542,948
+6,384
+1% +$78.4K ﹤0.01% 2970
2019
Q2 		$7.87M Buy
536,564
+36,547
+7% +$528K ﹤0.01% 2988
2019
Q1 		$7.61M Buy
500,017
+161,859
+48% +$2.02M ﹤0.01% 2971
2018
Q4 		$3.38M Buy
338,158
+4,071
+1% +$55K ﹤0.01% 3216
2018
Q3 		$5.38M Buy
+334,087
New +$5.86M ﹤0.01% 3209

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Vanguard Group's REPL Position: Q4 2025 in Review

Vanguard Group increased its Replimune Group (REPL) stake by 8.5% in Q4 2025, buying an estimated $2.52M and bringing the position to 3,776,198 shares worth $36.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

Vanguard Group first reported a position in REPL in Q3 2018 and has held it in 30 quarters since. The position peaked at $61M in Q4 2022. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • Vanguard Group held 3,776,198 shares of Replimune Group worth $36.7M as of Q4 2025.
  • Vanguard Group bought 296,803 Replimune Group shares in Q4 2025, an estimated $2.52M.
  • Replimune Group made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2335 holding.
  • Vanguard Group first reported a position in Replimune Group in Q3 2018 and has held it in 30 quarters since.
  • Vanguard Group's Replimune Group position peaked at $61M in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.